PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells. Mangiapane LR, Nicotra A, Turdo A, Gaggianesi M, et al. Gut 2021 Jan 12. pii: gutjnl-2020-323553. doi: 10.1136/gutjnl-2020-323553.

Read + Share

Amedeo Smart

Independent Medical Education

Mangiapane LR, Nicotra A, Turdo A, Gaggianesi M, et al. PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells. Gut 2021 Jan 12. pii: gutjnl-2020-323553. doi: 10.1136/gutjnl-2020-323553.
PMID: 33436496